Retatrutide is a next-generation triple-agonist research peptide studied for its activity on GLP-1, GIP, and glucagon receptor pathways. By engaging all three metabolic receptors, Retatrutide is explored in advanced research focused on appetite regulation, energy expenditure, and comprehensive metabolic signaling.
Its multi-pathway mechanism has made Retatrutide a compound of interest in laboratory studies examining weight-management pathways, metabolic efficiency, and glucose-related signaling, offering a broader receptor profile than dual-agonist compounds.
Triple-agonist activity (GLP-1, GIP, glucagon receptors)
Studied for appetite, energy balance, and metabolic signaling
Explored in advanced weight-management research
Long-acting research peptide profile
This product is sold for research and laboratory use only. Not for human consumption.
| Weight | 0.0283495 kg |
|---|
Discount Applied Successfully!
Your savings have been added to the cart.
